Original Papers (1990-2000)
  1. Suhara T.,Nishikawa Y.,Shimizu M.,Mori A.,Oshibuti M.,Kawakami K.The diagnosis of the Pick disease by SPECT - Comparison with Alzheimer's disease. Gerontopsychiatry,4:634-640,1987[in Japanese]


  2. Suhara T.,Shimizu T.,Sunada Y.,Nishimura Y.A case report; toluene inhalation induced distal renal tubular acidosis.The Journal of the Japanese Society of Internal Medicine,77:1452-1453,1988[in Japanese]


  3. Suhara T.,Inoue O.,Kobayashi K. Effect of desipramine on dopamine receptor binding in vivo Life Sci 47:2119-2126,1990


  4. Suhara T.,Fukuda H.,Inoue O.,Itoh T., Suzuki K.,Yamasaki T.,Tateno Y. Age-related changes in human D1 dopamine receptors measured by positron emission tomography Psychopharmacology, 103:41-45,1991


  5. Inoue O.,Tsukada H.,Yonezawa H.,Suhara T.,Langstrom B. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine. Eur J Pharmacol, 197:143-149,1991


  6. Inoue O.,Tsukada H.,Kobayashi K.,Suhara T.,Itoh T. Swim stress alters in vivo binding of [3H]N-methylspiperone Neuropharmacology, 30:1101-1106,1991


  7. Yonezawa H.,Iyo M.,Ito T.,Fukuda H.,Yamazaki T.,Inoue O.,Suhara T.,Shinoto H.,Nishio M.,Togi H.,Tateno Y. Age - related changes of methylspiperone binding.The Japanese journal of nuclear medicine,28:63-69,1991[in Japanese]


  8. Hasegawa T.,Nakayama K.,Suhara T.,Nukariya K.,Kasahara H.,Shimizu M.,Mori A. A case report; predominantly unilateral cerebral hemisphere atrophy presented with presenium - onset dementia. Japanese journal of geriatric psychiatry ,2:1109-1113,1991[in Japanese]


  9. Suhara T.,Nakayama K.,Inoue O.,Fukuda H.,Shimizu M.,Mori A.,Tateno Y. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology, 106:14-18,1992


  10. Inoue O.,Kobayashi K.,Suhara T. Effect of sedative drugs upon receptor binding in vivo. Prog Neuro-Psychopharmacol&Biol Psychiat, 16:783-789,1992


  11. Inoue O.,Suhara T.,Itho T.,Kobayashi K.,Suzuki K.,Tateno Y. In vivo binding of [11C]Ro15-4513 in human brain measured with PET. Neurosci Lett, 145:133-136,1992


  12. Kagaya A.,Fukuda K.,Endo M.,Himi T.,Niwayama H.,Masuda Y.,Inagaki Y.,Suzuki K.,Suhara T.,Yamazaki T.,Tateno Y. Kinetic analysis of N13 - ammonia in lung by PET - The influence of smoking - The Japanese journal of nuclear medicine,29:1099-1106,1992[in Japanese]


  13. Suhara T.,Inoue O.,Kobayashi K.,Suzuki K.,Tateno Y. Age-related changes in human muscarinic acetylcholine receptors measured by positoron emission tomography. Neurosci Lett, 149:225-228,1993


  14. Shinotoh H.,Inoue O.,Hirayama K.,Aotsuka A.,Asahina M.,Suhara T.,Yamazaki T.,Tateno T. Dopamine D1receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J Neurol Nerosurg Psychiatry, 56:467-472,1993

  15. Suhara T.,Inoue O.,Kobayashi K.,Suzuki K.,Itoh T.,Tateno Y. No age-related changes in human benzodiazepine receptor binding measured by PET with [11 C]Ro 15-4513. Neurosci Lett159:207-210,1993

  16. Suhara T.,Yoshikawa S.,Sishido F.,Fukuda H. Trial production of head fixation system for positron CT.The Japanese journal of nuclear medicine , 33:1241-1244,1993[in Japanese]


  17. Suhara T.,Inoue O.,Kobayashi K.,Satoh T.,Tateno Y. An acute effect of triazolam on muscarnic cholinergic receptor binding in the human brain measured by positron emission tomography. Psychopharmacology,113:311-317,1994

  18. Sedvall G.,Karlsson P.,Lundin A.,Anvret M.,Suhara T.,Halldin C.,Farde L. Dopamine D1 receptor number - a sensitive PET marker for early brain degeneration in Huntington's disease. Eur Arch Psychiatry Clin Neurosci,243:249-255,1994

  19. Farde L.,Halldin C.,Muller L.,Suhara T.,Karlsson P.,Hall H. PET study of [11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse,16:93-103,1994

  20. Shinotoh H.,Asahina M.,Inoue O.,Suhara T.,Hirayama K.,Tateno Y. Effects of trihexyphenidyl and L-dopa on brain muscarinic cholinergic receptor binding measured by positron emission tomography. J Neural Transm[P-D Sect], 7:35-46,1994

  21. Farde L.,Halldin C.,Nagren K.,Suhara T.,Karlsson P.,Schoeps K-O.,Swahn C-G.,Bone D. Positron emission tomography shows high specefic uptake of racemic carbon-11 labelled norepinephrine in the primate heart. Eur J Nucl Med,,21:345-347,1994

  22. Asahina M.,Shinotoh H.,Hirayama K.,Suhara T.,Shishido F.,Inoue O.,Tateno Y. Hypersensitivity of cortical muscarnic receptors in Parkinson's disease demonstrated by PET. Acta Neurol Scand 91:437-443,1995

  23. Halldin C.,Farde L.,Hogberg T.,Mohell N.,Hall H.,Suhara T.,Karlsson P.,Nakashima T., Swahn C-G. Carbon-11-FLB 457: A radioligand for extrastriatal D2 dopamine receptors. J Nucl Med,36:1275-1281,1995

  24. Farde L.,Halldin C.,Nagren K.,Karlsson P.,Swahn C-G.,Suhara T. PET examination of the monkey heart with high specific radioactivity [11C]norepinephrine and [11C]metaraminol. Nucl Med Biol,22:1053-1056,1995

  25. Suhara T.,Farde L.,Halldin C.,Nagren K.,Karlsson P. Effects of cocaine on [11C]norepinephrine and [11C]β-CIT uptake in the primate peripheral organs measured by PET. Ann Nucl Med,10:85-88,1996

  26. Nagren K.,Halldin C.,Swahn C-G.,Suhara T.,Farde L. [11C]metaraminol,a false neurotransmitter: preparation, metabolite studies and positron emission tomography examination in monkey. Nucl Med Biol,23:221-227,1996

  27. Foged C.,Halldin C.,Hiltunen J.,Braestrup C.,Thomsen C.,Hansen H.C.,Suhara T.,Pauli S., Swahn C.-G.,Karlsson P.,Larsson S.,Farde L. Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding. Nucl Med Biol,23:201-209,1996

  28. Farde L.,Suhara T.,Halldin C.,Nyback H.,Nakashima Y.,Swahn C-G.,Karlsson P.,Ginovart N., Bymaster EP.,Shannon HE.,Foged C.,Suzdak PD.,Sauerberg P. PET study of the M1-agonists[11C]xanomeline and [11C]butylthio-TZTP in monkey and man. Dementia,7:187-195,1996

  29. Muller L.,Halldin C.,Lundkvist C.,Swahn C.-G.,Foged C.,Hall H.,Karlsson P.,Ginocart N., Nakashima Y.,Suhara T.,Farde L. Development of radioligands for the dopamine transporter. J Radioanal Nucl Ch, 206:133-144,1996

  30. Sasaki M.,Suhara T.,Kubodera A.,Suzuki K. [11C]McN5652-X for injection of modified automatic synthesis and these kinetics of human and mouse in vivo.The japanese journal of nuclear medicine,33:1319-1327,1996[in Japanese]


  31. Okubo Y.,Suhara T.,Suzuki K.,Kobayashi K.,Inoue O.,Terasaki O.,Someya Y.,Sassa T., Sudo Y.,Matsuchima E.,Iyo M.,Tateno Y.,Toru M. Decreased Prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature,385:634-636,1997

  32. Iyo M.,Namba H.,Fukushi K.,Shinotoh H.,Nagatsuka S.,Suhara T.,Sudo Y.,Suzuki K.,Irie T. Measurement of acetylocholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease. Lancet,349:1805-1809,1997

  33. Okubo Y.,Suhara T.,Sudo Y.,Toru M. Possible role of dopamine D1 receptors in schizophrenia. Mol Psychiatr,2:291-292,1997

  34. Farde L.,Suhara T.,Nyberg S.,Karlsson P.,Nakashima Y.,Hietala J.,Halldin C. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology,133:396-404,1997

  35. Foged C.,Halldin C.,Loc'h C.,Maziere B.,Pauli S.,Maziere M.,Hansen HC.,Suhara T., Swahn C-G.,Karlsson P.,Farde L. Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable Benzodiazepine receptor agonists as radioligands for positron emission tomography (PET). Eur J Nucl Med,24:1261-1267,1997

  36. Suhara T.,Sudo Y.,Yoshida K.,Okubo Y.,Fukuda H.,Obata T.,Yoshikawa K.,Suzuki K.,Sasaki Y. Lung as reservoir for antidepressants in oharmacokinetic drug interactions. Lancet,351:332-335,1998

  37. Asahina M.,Suhara T.,Shinotoh H.,Inoue O.,Suzuki K.,Hattori T. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: A positron emission tomographic study. J Neurol Neurosurg Psychiatry65:155-163,1998

  38. Sudo Y.,Suhara T.,Honda Y.,Nakajima T.,Okubo Y.,Suzuki K.,Nakashima Y.,Yoshikawa K., Okauchi T.,Sasaki Y.,Matsushita M. Muscarnic cholionergic receptors in human narcolepsy A PET study. Neurology,51:1297-1302,1998

  39. Sudo Y.,Suhara T.,Suzuki K.,Okubo Y.,Yoshikawa K.,Uchida S.,Sassa T.,Okauchi T.,Sasaki Y., Matsushita M. Muscarinic receptor occupancy by biperiden in living human brain. Life Sci,64:PL99-104,1999

  40. Namba H.,Iyo M.,Fukushi K.,Shinotoh H.,Nagatsuka S.,Suhara T.,Sudo Y.,Suzuki K., Irie T. Human cerebral acetylcholinesterase acivity measured with positron emission tomography: procedure, normal values and effect of age. Eur J Nucl Med,26:135-143,1999

  41. Semba J.,Sakai MW.,Suhara T.,Akanuma N. Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization. Neurochem Int,34:267-277,1999

  42. Suhara T.,Sudo Y.,Okauchi T.,Maeda J.,Kawabe K.,Suzuki K.,Okubo Y.,Nakashima Y., Ito H.,Tanada S.,Halldin C.,Farde L. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. Int J Neuropsychopharmacol,2:73-82,1999

  43. Okubo Y.,Olsson H.,Ito H.,Lofti M.,Suhara T.,Halldin C.,Farde L. PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457. NeuroImage,10:666-674,1999

  44. Okubo Y.,Suhara T.,Suzuki K.,Kobayashi K.,Inoue O.,Terasaki O.,Someya Y.,Sassa T.,Sudo Y., Matsushima E.,Iyo M.,Tateno Y.,Toru M. Serotonin 5-HT2 Receptors in Schizophrenic Patients studied by positron emission tomography. Life Sci66:2455-2464,2000

  45. Ishibashi N.,Kuwamura T.,Sano H.,Yamamoto F.,Haradahira T.,Suzuki K.,Suhara T.,Sasaki S.,Maeda M. Synthesis and Evaluation of 18F- and 11C-Labelled 9,10-Ethanobenzo [β]quinolizinium Derivatives for Imaging of the NMDA Receptor at the TCP-Binding Site. J.Labelled.Compd.Radiopharm. 43:375-383,2000

  46. Someya Y.,Obata T.,Suhara T.,Ota Y.,Ikehira H.,Tanada S.,Hirakawa K.,Okubo Y.,Sasaki Y. Seizure frequency and bilateral temporal abnormalities: a proton magnetic resonance spectroscopy of temporal lobe epilepsy. Seizure9:274-279,2000

  47. Semba J.,Watanabe H.,Suhara T.,Akanuma N. Neonatal treatment with L-name (NG-nitro-L-arginine methyl ester) attenuates stereotyped behavior induced by acute methamphetamine but not development of behavioral sensitization to methamphetamine. Prog.Neuro-Psychopharmacol.&Biol.Psychiat 24:1017-1023,2000

  48. Haradahira T.,Zhang M-R.,Maeda J.,Okauchi T.,Kawabe K.,Kida T.,Suzuki K.,Suhara T. A strategy for incresing the brain uptake of a radioligand in animals: use of a drug that inhibits plasma protein binding. Nuc Med Biol27:357-360,2000

  49. Semba J.,Watanabe H.,Suhara T.,Akanuma N. Chronic lithium chloride injection increases glucocorticoid receptor but not mineralocorticoid receptor mRNA expression in rat brain. Neurosci Res38:313-319,2000

Original Papers (1990-2000)